psoriatic%20arthritis
PSORIATIC ARTHRITIS
Psoriatic arthritis is a chronic inflammatory arthropathy associated with cutaneous psoriasis.
It is a progressive disease with asymmetric joint distribution pattern and rheumatoid factor is negative.
It can develop at any time including childhood but most often occurs between 30-50 years old.
Symptoms may range from mild to very severe.

Psoriatic%20arthritis Signs and Symptoms

Introduction

  • Psoriatic arthritis is a chronic inflammatory seronegative spondyloarthropathy associated w/ psoriasis
  • 6-42% of patients w/ psoriasis may develop psoriatic arthritis
  • Usually develops after an average of 12 yr of cutaneous manifestations
    • Dermatologists are encouraged to monitor for signs & symptoms of psoriatic arthritis every visit
    • All patients suspected of having psoriatic arthritis should be assessed by a rheumatologist so that an early diagnosis can be made & joint damage can be reduced 
  • Can develop at any time including childhood but most often occurs between 30-50 yr old
  • Affects men & women equally

Signs and Symptoms

  • Signs & symptoms include:
    • Peripheral joint pain, stiffness & swelling
    • Axial joint pain, stiffness & swelling
    • Tenderness of the joint & surrounding ligaments & tendons
    • Presence of skin & nail lesions
    • Enthesitis, tenosynovitis & dactylitis
    • Extra-articular manifestations (ie uveitis) 
  • Symptoms range from mild to very severe
    • Severity of the skin disease & the arthritis do not correlate w/ each other
    • Nail disease is commonly found in patients w/ psoriatic arthritis especially those w/ distal interphalangeal joint involvement
    • Psoriatic arthritis may start slowly w/ mild symptoms or may be preceded by a joint injury
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 5 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 20 Oct 2020
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Nocturia is a risk factor for mortality, according to the results of the Nagahama Study, which boasts of a low incidence of missing data and high representation of the general population.